Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1150 of 2051 entries
View as:

Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT00357279 Org: User:
Start: 07/31/06 End: 09/30/08 Due: 09/30/09

Pediatric Expanded Access Program-Oral Solution (0831-908)

Phase: N/A Priority: Normal
NCT ID: NCT00543530 Org: User:
Start: 03/31/01 End: 12/31/02 Due: 12/31/03

A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003)

Phase: N/A Priority: Normal
NCT ID: NCT01215188 Org: User:
Start: 10/14/10 End: 07/31/12 Due: 07/31/13

Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)

Phase: N/A Priority: Normal
NCT ID: NCT00662818 Org: User:
Start: 03/17/08 End: 09/02/09 Due: 09/02/10

A Study of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Opioid Use Disorder (MK-4305-098)

Phase: N/A Priority: Normal
NCT ID: NCT06655883 Org: User:
Start: 10/13/25 End: 06/24/27 Due: 06/24/28

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)

Phase: N/A Priority: Normal
NCT ID: NCT05239741 Org: User:
Start: 04/02/22 End: 09/19/28 Due: 09/19/29

A Study of Belzutifan (MK-6482) in Participants With Hepatic Impairment (MK-6482-020)

Phase: N/A Priority: Normal
NCT ID: NCT04995484 Org: User:
Start: 06/24/22 End: 01/03/24 Due: 01/03/25

A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)

Phase: N/A Priority: Normal
NCT ID: NCT00489099 Org: User:
Start: 06/30/05 End: 05/31/06 Due: 05/31/07

Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)

Phase: N/A Priority: Normal
NCT ID: NCT01043926 Org: User:
Start: 02/22/10 End: 04/14/10 Due: 04/14/11

A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370)

Phase: N/A Priority: Normal
NCT ID: NCT01636960 Org: User:
Start: 12/25/12 End: 11/04/15 Due: 11/04/16

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

Phase: N/A Priority: Normal
NCT ID: NCT04700124 Org: User:
Start: 04/21/21 End: 12/23/26 Due: 12/23/27

Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)

Phase: N/A Priority: Normal
NCT ID: NCT01567813 Org: User:
Start: 06/23/11 End: 06/01/19 Due: 06/01/20

Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)

Phase: N/A Priority: Normal
NCT ID: NCT04626479 Org: User:
Start: 12/16/20 End: 05/31/26 Due: 05/31/27

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Phase: N/A Priority: Normal
NCT ID: NCT00092534 Org: User:
Start: 06/14/02 End: 06/15/25 Due: 06/15/26

Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002)

Phase: N/A Priority: Normal
NCT ID: NCT01324440 Org: User:
Start: 09/30/06 End: 10/31/07 Due: 10/31/08

A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Lot Consistency of V116 in Adults 18 to 49 Years of Age (V116-004, STRIDE-4)

Phase: N/A Priority: Normal
NCT ID: NCT05464420 Org: User:
Start: 08/12/22 End: 05/25/23 Due: 05/25/24

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Phase: N/A Priority: Normal
NCT ID: NCT01048671 Org: User:
Start: 01/31/10 End: 12/31/12 Due: 12/31/13

Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003)

Phase: N/A Priority: Normal
NCT ID: NCT01934647 Org: User:
Start: 11/22/13 End: 09/08/14 Due: 09/08/15

Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)

Phase: N/A Priority: Normal
NCT ID: NCT00749398 Org: User:
Start: 09/30/07 End: 09/30/10 Due: 09/30/11

Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)

Phase: N/A Priority: Normal
NCT ID: NCT01545388 Org: User:
Start: 02/23/12 End: 03/12/13 Due: 03/12/14

Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)

Phase: N/A Priority: Normal
NCT ID: NCT00664287 Org: User:
Start: 09/30/08 End: - Due: -

Gluten Challenge Study in Celiac Disease Participants (MK-0000-402)

Phase: N/A Priority: Normal
NCT ID: NCT04054544 Org: User:
Start: 08/28/20 End: 06/23/21 Due: 06/23/22

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)

Phase: N/A Priority: Normal
NCT ID: NCT02105701 Org: User:
Start: 06/05/14 End: 06/19/15 Due: 06/19/16

A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension

Phase: N/A Priority: Normal
NCT ID: NCT04525885 Org: User:
Start: 05/17/19 End: 09/15/22 Due: 09/15/23

A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)

Phase: N/A Priority: Normal
NCT ID: NCT06442436 Org: User:
Start: 07/24/24 End: 12/12/25 Due: 12/12/26